Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Pryce · SciRah

Researcher profile · Semantic Scholar

G. Pryce

Share profile

G. Pryce — researcher profile on SciRah

h-index: 47
Works: 127
Citations: 7,304

Most-cited papers

Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.
L. Cristino, L. de Petrocellis, G. Pryce, D. Baker +2 more
2006Neuroscience496 citations
Semantic Scholar
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
K. Maresz, G. Pryce, E. Ponomarev, G. Marsicano +14 more
2007Nature Medicine363 citations
Semantic Scholar
In silico patent searching reveals a new cannabinoid receptor.
D. Baker, G. Pryce, Wayne I. L. Davies, C. Hiley
2006TIPS - Trends in Pharmacological Sciences360 citations
Semantic Scholar
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
G. Pryce, Z. Ahmed, D. Hankey, S. Jackson +8 more
2003Brain : a journal of neurology353 citations Open access
Semantic Scholar
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
D. Baker, M. Marta, G. Pryce, G. Giovannoni +1 more
2017EBioMedicine272 citations Open access
Semantic Scholar
MicroRNA‐155 negatively affects blood–brain barrier function during neuroinflammation
M. Lopez-Ramirez, Dongsheng Wu, G. Pryce, J. Simpson +10 more
2014The FASEB Journal256 citations Open access
Semantic Scholar
Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis
J. Greenwood, C. Walters, G. Pryce, N. Kanuga +3 more
2003The FASEB Journal241 citations Open access
Semantic Scholar
Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice
L. Bilsland, J. Dick, G. Pryce, S. Petrosino +3 more
2006The FASEB Journal150 citations
Semantic Scholar
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases
D. Baker, C. Roberts, G. Pryce, Angray S. Kang +5 more
2020Clinical and Experimental Immunology147 citations Open access
Semantic Scholar
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.
J. Anderson, David W. Hampton, R. Patani, G. Pryce +8 more
2008Brain : a journal of neurology132 citations Open access
Semantic Scholar
Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors
G. Pryce, D. Baker
2007British Journal of Pharmacology128 citations Open access
Semantic Scholar
The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis.
D. Baker, G. Pryce, L. James, M. Marta +1 more
2020Multiple Sclerosis and Related Disorders122 citations Open access
Semantic Scholar
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.
E. de Lago, A. Ligresti, G. Ortar, E. Morera +6 more
2004European Journal of Pharmacology100 citations
Semantic Scholar
Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
J. Croxford, G. Pryce, S. Jackson, C. Ledent +4 more
2008Journal of Neuroimmunology98 citations
Semantic Scholar
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis
Simon Licht-Mayer, Graham R. Campbell, Marco A Cañizares, A. Mehta +33 more
2020Acta Neuropathologica88 citations Open access
Semantic Scholar
Brain Endothelial miR-146a Negatively Modulates T-Cell Adhesion through Repressing Multiple Targets to Inhibit NF-κB Activation
Dongsheng Wu, C. Cerutti, M. Lopez-Ramirez, G. Pryce +10 more
2015Journal of Cerebral Blood Flow and Metabolism88 citations Open access
Semantic Scholar
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation.
S. Jackson, G. Pryce, L. Diemel, M. Cuzner +1 more
2005Neuroscience84 citations
Semantic Scholar
Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis
J. Warne, G. Pryce, J. Hill, Xiaojie Shi +13 more
2015Journal of Biological Chemistry83 citations Open access
Semantic Scholar
Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects?
J. D. Wilkinson, Benjamin J. Whalley, D. Baker, G. Pryce +3 more
200380 citations Open access
Semantic Scholar
Emerging properties of cannabinoid medicines in management of multiple sclerosis.
G. Pryce, D. Baker
2005Trends in Neurosciences79 citations
Semantic Scholar
A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis.
E. East, D. Baker, G. Pryce, H. Lijnen +2 more
2005American Journal of Pathology76 citations Open access
Semantic Scholar
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.
G. Pryce, J. K. O'Neill, J. Croxford, S. Amor +4 more
2005Journal of Neuroimmunology76 citations
Semantic Scholar
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.
E. de Lago, J. Fernández-Ruiz, S. Ortega-Gutiérrez, A. Cabranes +4 more
2006European Neuropsychopharmacology75 citations
Semantic Scholar
Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction
Matthew E. Gegg, R. Harry, D. Hankey, H. Zambarakji +5 more
2005Journal of Immunology74 citations Open access
Semantic Scholar
Cannabinoid control of neuroinflammation related to multiple sclerosis
D. Baker, S. Jackson, G. Pryce
2007British Journal of Pharmacology73 citations Open access
Semantic Scholar
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis
A. Ligresti, M. Cascio, G. Pryce, Sanjitha Kulasegram +10 more
2006British Journal of Pharmacology73 citations Open access
Semantic Scholar
Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
S. Al‐Izki, G. Pryce, J. K. O'Neill, C. Butter +3 more
2012Multiple Sclerosis and Related Disorders71 citations Open access
Semantic Scholar
An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss.
David W. Hampton, J. Anderson, G. Pryce, K. Irvine +6 more
2008Journal of Neuroimmunology70 citations
Semantic Scholar
Potential mechanisms of action related to the efficacy and safety of cladribine.
D. Baker, G. Pryce, Samuel S. Herrod, K. Schmierer
2019Multiple Sclerosis and Related Disorders67 citations
Semantic Scholar
Cannabinoids and neuroprotection in CNS inflammatory disease.
S. Jackson, L. Diemel, G. Pryce, D. Baker
2005Journal of Neurological Sciences64 citations
Semantic Scholar
Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis
S. Al‐Izki, G. Pryce, S. Jackson, G. Giovannoni +1 more
2011Multiple Sclerosis57 citations
Semantic Scholar
The endocannabinoid system and multiple sclerosis.
D. Baker, G. Pryce
2008Current pharmaceutical design54 citations
Semantic Scholar
Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis.
D. Baker, G. Pryce, S. Amor, G. Giovannoni +1 more
2018Brain : a journal of neurology51 citations Open access
Semantic Scholar
Depletion of CD52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting CD8 T‐cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis
S. von Kutzleben, G. Pryce, G. Giovannoni, D. Baker
2017Immunology51 citations Open access
Semantic Scholar
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
G. Pryce, D. Riddall, David L. Selwood, G. Giovannoni +1 more
2015Journal of Neuroimmune Pharmacology51 citations
Semantic Scholar
Oligoclonal bands in multiple sclerosis; Functional significance and therapeutic implications. Does the specificity matter?
G. Pryce, D. Baker
2018Multiple Sclerosis and Related Disorders49 citations Open access
Semantic Scholar
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis
S. Sisay, G. Pryce, S. Jackson, Carolyn Tanner +5 more
2013PLoS ONE49 citations Open access
Semantic Scholar
Quantification of neurodegeneration by measurement of brain-specific proteins.
A. Petzold, David Baker, G. Pryce, G. Keir +2 more
2003Journal of Neuroimmunology49 citations Open access
Semantic Scholar
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
S. Al‐Izki, G. Pryce, D. Hankey, K. Lidster +17 more
2014Brain : a journal of neurology44 citations
Semantic Scholar
Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis
D. Baker, G. Pryce, L. James, K. Schmierer +1 more
2020European Journal of Neurology42 citations
Semantic Scholar
Increased expression of colony‐stimulating factor‐1 in mouse spinal cord with experimental autoimmune encephalomyelitis correlates with microglial activation and neuronal loss
Svetlana Gushchina, G. Pryce, P. Yip, Dongsheng Wu +4 more
2018Glia40 citations Open access
Semantic Scholar
The therapeutic potential of cannabis in multiple sclerosis
D. Baker, G. Pryce
2003Expert Opinion on Investigational Drugs40 citations
Semantic Scholar
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
G. Pryce, D. Baker
2015Handbook of Experimental Pharmacology39 citations
Semantic Scholar
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis
A. Hilliard, C. Stott, S. Wright, G. Guy +4 more
2012ISRN Neurology39 citations Open access
Semantic Scholar
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors
G. Pryce, A. Cabranes, J. Fernández-Ruiz, T. Bisogno +5 more
2013Multiple Sclerosis38 citations
Semantic Scholar
Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice
L. Peferoen, M. Breur, S. van de Berg, R. Peferoen‐Baert +6 more
2016Immunology37 citations Open access
Semantic Scholar
Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects?
J. D. Wilkinson, Benjamin J. Whalley, D. Baker, G. Pryce +3 more
2003The Journal of pharmacy and pharmacology36 citations
Semantic Scholar
Potential control of multiple sclerosis by cannabis and the endocannabinoid system.
G. Pryce, D. Baker
2012CNS and Neurological Disorders - Drug Targets34 citations
Semantic Scholar
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
David W. Hampton, Andrea Serio, G. Pryce, S. Al‐Izki +4 more
2013Acta Neuropathologica Communications33 citations Open access
Semantic Scholar
Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice.
A. Cabranes, G. Pryce, D. Baker, J. Fernández-Ruiz
2006Brain Research32 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Baker×26
Invite
D. Baker — researcher profile on SciRah
G. Giovannoni×15
Invite
G. Giovannoni — researcher profile on SciRah
D. Baker×10
Invite
D. Baker — researcher profile on SciRah
S. Jackson×7
Invite
S. Jackson — researcher profile on SciRah

×7

Invite

D. Baker — researcher profile on SciRah

K. Schmierer×6

Invite

K. Schmierer — researcher profile on SciRah

Invite

S. Amor — researcher profile on SciRah

G. Giovannoni×5

Invite

G. Giovannoni — researcher profile on SciRah

S. Al‐Izki×5

Invite

S. Al‐Izki — researcher profile on SciRah

Invite

V. Di Marzo — researcher profile on SciRah

Invite

J. Croxford — researcher profile on SciRah

Invite

D. Hankey — researcher profile on SciRah